설립배경
B-Light Investment was founded on May 26, 2023, with the mission
of discovering high-potential ventures that will lead the future of
the bio-healthcare industry and growing alongside them.
Capital
Assets under management
as of December 31, 2024
A Partner That Shines Light, WHY WE EXIST?
At B-Light Investment, we are more than a provider of capital – we are a partner that brings light to the future of bio-healthcare.
Our core mission is to uncover innovation in unexplored areas and become the most trusted partner driving a healthier world.
With over 60 years of dedication to advancing human health, the Pharmgen Science Group has remained steadfast in its values.
Beyond financial gains, our purpose is to support the sustainable growth of our portfolio companies and, ultimately, to benefit humanity.
We are a constant partner where innovation takes root, creates value, and shapes a better future.
Our philosophy is both the foundation of our spirit and the compass guiding our path forward.
Business Development Engine through Open Innovation Team:
The core of our investment process is the role of the Open Innovation Team.
The Open Innovation Team serves as the execution engine that plans and drives new healthcare businesses for our group.
Leveraging this strong execution capability, we spearhead global market expansion into regions such as the United States and China, incubating and accelerating the growth of our portfolio companies. By leading practical operations—including sales, marketing, and international expansion—we drive revenue growth, expand markets, and create synergies with existing group businesses.
This goes beyond simple financial support; it is the core engine that generates B-Light Investment’s distinguished value.
